Time

From Phase III prostate cancer trials to first-in-human adaptive radiotherapy, Siteman Cancer Center will highlight major advances at the 68th ASTRO Annual…

From Phase III prostate cancer trials to first-in-human adaptive radiotherapy, Siteman Cancer Center will highlight major advances at the 68th ASTRO Annual…

WashU Medicine investigator at Siteman Cancer Center aims to study how chemical modifications to RNA contribute to the progression of multiple myeloma Jessica Silva-Fisher, PhD, a WashU Medicine scien...

FDA approves first-in-class drug trialed at WashU Medicine and Siteman Cancer Center — a new option for patients with metastatic disease Daraxonrasib is a drug that targets RAS proteins, which are mut...

WashU Oncologist discusses local research on pancreatic cancer, the symptoms to watch for, and the treatments available.

FDA approves first-in-class drug trialed at WashU Medicine and Siteman Cancer Center — a new option for patients with metastatic disease Daraxonrasib is a drug that targets RAS proteins, which are mut...

Timothy J. Ley, MD, a research member at Siteman Cancer Center, has been elected as a member of the American Philosophical Society.

Siteman Cancer Center served as a major and early clinical trial site for the research, which studied the vaccine combined with Keytruda given after surgery.

The WashU Medicine physician-scientist at Siteman Cancer Center is focused on a major challenge in treatment for hormone receptor-positive breast cancer.

The honor is in recognition of their development of an AI tool that refines breast-cancer risk prediction.

Gregory Zipfel, MD, of WashU Medicine and Siteman Cancer Center, now leads the world's oldest neurosurgical society, founded to advance neurosurgical care.

Cancer cells are ravenous eaters. Gary Patti is trying to turn their hunger against them. By their nature, cancer cells have different nutritional needs - Siteman Cancer Center

Renowned physician-scientist is national leader in research and treatment of blood cancers Ravi Vij, MD, MBA, who has dedicated his career to advancing - Siteman Cancer Center

According to results of a large cohort study from the Veterans Health Administration database, a new lung cancer screening metric centering on tobacco smoking duration decreases potentially missed can...

Long-term RUBY data show dostarlimab plus chemo drives durable remission and potential cure in many dMMR/MSI-H advanced or recurrent endometrial cancer patients.